225.78BMarket Cap13.26P/E (TTM)
91.370High88.860Low13.53MVolume91.300Open91.430Pre Close1.21BTurnover0.54%Turnover Ratio13.26P/E (Static)2.53BShares132.67152wk High4.88P/B225.42BFloat Cap81.04052wk Low3.12Dividend TTM2.52BShs Float132.671Historical High3.49%Div YieldTTM2.75%Amplitude17.857Historical Low89.533Avg Price1Lot Size
Merck & Co Stock Forum
Can Merck's KEYTRUDA Transform Head and Neck Cancer Treatment After 20-Year Stagnation?
As I've been suggesting recently, this sell-off was likely to occur for a couple of key reasons. We’ve had a round of bad news, so we are awaiting good news to break us higher. But traders are bracing for dis...
Esperion Therapeutics (ESPR), currently trading under $2 per share, has been attracting considerable attention from analysts. Recently, three analysts reaffirmed strong "Buy" ratings, with price targets ranging from $5 to $16 per share. Among the nine analysts covering Esperion, seven h...
less than 60s, big whale swallowed it
Breakthrough: First-Ever Oral Treatment for VHL Disease Gets EU Green Light - Merck's WELIREG Shows Remarkable 83% Response Rate
Iron Mountain Incorporated (IRM US) $Iron Mountain (IRM.US)$
Daily Chart - [BEARISH ↘ **] IRM US shaped a bearish breakout and is holding below a descending trendline. As long as price is holding below resistance at 102.00, a further push down towards 87.20 support is expected. The MACD is showing bearish momentum as well.
Alternatively: A daily candlestick closing above 102.00 resistance will invalidate bearish view...
No comment yet